# The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes

> **NCT04796779** · NA · COMPLETED · sponsor: **Marc Breton** · enrollment: 102 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Tandem t:slim X2 with Control-IQ Technology Pro
- **DEVICE:** Standard Care (SC)
- **DEVICE:** Tandem t:slim X2 with Control-IQ Technology V1.5

## Key facts

- **NCT ID:** NCT04796779
- **Lead sponsor:** Marc Breton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-07-31
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04796779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04796779, "The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04796779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*